IL2RA and melanoma: In the current study, the clinical and immunologic effects of a single dose of denileukin diftitox (as a strategy to target CD25-expressing cells) prior to multi-peptide vaccination were compared with multi-peptide vaccination alone in HLA-A2+ subjects with advanced melanoma.